Martha Solomon
Foot & Ankle Surgery · Delray Beach, FLNPI 1861411787
Payments from drug & device makers
Across 27 payments — averaging $25.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$170
- Bioventus LLC$70
- Amgen$67
- Organogenesis Inc.$46
- DJO, LLC$46
- Johnson & Johnson$45
- plus $250 from 9 others
What the payments were for
- Food & beverage$693100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 5 | $170 |
| Bioventus LLC | 4 | $70 |
| Amgen | 3 | $67 |
| Organogenesis Inc. | 2 | $46 |
| DJO, LLC | 2 | $46 |
| Johnson & Johnson | 2 | $45 |
| Osiris Therapeutics Inc. | 1 | $41 |
| Dynasplint Systems Inc. | 1 | $35 |
| Treace Medical Concepts, Inc. | 1 | $35 |
| Averitas Pharma Inc. | 1 | $32 |
| KCI USA, Inc. | 1 | $27 |
| Akcea Therapeutics, Inc. | 1 | $26 |
| Zyla Life Sciences, Inc. | 1 | $20 |
| Biotronik NRO, Inc. | 1 | $19 |
| Zimmer Biomet | 1 | $14 |
How this compares
$693 in reported general payments places this provider in the 20th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 33 | $874 |
| Cephalexin | 19 | $463 |
| Mupirocin | 38 | $239 |
| Gabapentin | 11 | $112 |
| Meloxicam | 19 | $83 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Delray Beach
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
- Mario CalaHialeah$544K
- Christopher ReevesLake Mary$437K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.